Triple Threat Blend (NAD+ / MOTS-c / 5-Amino-1MQ)
Metabolic and energy stack targeting fat loss and vitality.
For research purposes only. These products are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm these products will be used for legitimate research purposes.
About Triple Threat Blend (NAD+ / MOTS-c / 5-Amino-1MQ)
The Triple Threat blend combines NAD+ for mitochondrial energy and cellular repair, MOTS-c for AMPK-driven metabolic activation, and 5-Amino-1MQ, an NNMT inhibitor studied for fat metabolism. The three target cellular energy and fat handling through distinct pathways, positioned as an energy-and-body-composition protocol.
Key Benefits
- Multi-pathway metabolic activation
- Supports mitochondrial energy production
- Targets fat metabolism via NNMT inhibition
- Aims at energy and body composition together
Set a goal (top of the page) to see how Triple Threat Blend (NAD+ / MOTS-c / 5-Amino-1MQ) scores against it, and what the better-evidenced alternatives are.
Category Ratings
How to Take
Common Side Effects
- Flushing
- Nausea if injected too quickly
- Injection site reactions
- Fatigue
Legal & Regulatory Status
Research use only. Not FDA-approved. No studies exist on this specific combination; its components (NAD+, MOTS-c, 5-Amino-1MQ) have limited or preclinical-only evidence.
Safety and regulatory details for FDA-approved compounds are drawn from the official product label via openFDA; clinical development status reflects ClinicalTrials.gov. This information is provided for research reference, is not endorsed by the FDA, and may not be complete or current.
Research & Sources
No citations available. We could not locate indexed peer-reviewed literature for this compound specifically. That absence is the reason for its evidence rating — treat any claims about it, including ours, with corresponding caution.